 HAYWARD, Calif.--BUSINESS WIRE--Pulse Biosciences, Inc. Nasdaq: PLSE Pulse Biosciences or the Company a novel bioelectric medicine company progressing Nano-Pulse StimulationTM NPSTM technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 40,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive 